Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on TAKEDA PHARMACEUTICAL COMPANY LIMITED
Target Price consensus revisions : last 18 months
Recommendations (Chart) TAKEDA PHARMACEUTICAL COMPANY LIMITED
Analyst Recommendations on TAKEDA PHARMACEUTICAL COMPANY LIMITED
10/07TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight
MT
2020TAKEDA PHARMACEUTICAL : Japan's Takeda says drug pipeline to lift sales to $48 billion in next decade
RE
2018Takeda clears key hurdle as investors back $59 billion Shire deal
RE
2018Takeda investors back $59 billion Shire deal, but wary of debt load
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favour
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
RE
2018Japan's Takeda clinches ú45.3 billion Shire deal as pharma M&A rolls on
RE
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 3 070,00 JPY
Average target price 4 322,86 JPY
Spread / Average Target 40,8%
High Price Target 6 900,00 JPY
Spread / Highest target 125%
Low Price Target 3 200,00 JPY
Spread / Lowest Target 4,23%
Consensus detail
Consensus revision (last 18 months)